In this World of Cannabis Interview, watch Caroline Cahill, Managing Editor of MJINews.com and Marijuana Industry News magazine, interview Kevin Sutherland, CEO of Canna Mergers.
Tag Archives: Due Diligence
There are a number of big institutions, including mutual funds, pension funds, and investment banks, that use the TSX Composite and its sub-indices as performance benchmarks for their portfolios. The addition of Canopy to the index will introduce some new dimensions to the index’s performance.
Buying, selling or investing in any business requires proper due diligence. In the cannabis industry – you need to take extra steps. Hear Kevin Sutherland, CEO of Canna Mergers, and Paul Shively, a compliance expert, discuss the diligence you need to perform as you invest in the legal cannabis industry.
On Dec. 9, 2016, the Natalie M. LaPrade Maryland Medical Cannabis Commission named the 102 recipients of Stage One dispensary license pre-approvals, concluding the state’s application process for growers, processors and dispensaries.
You know, a random dude asked me just this morning how to get in on the cannabis industry. He had no idea what he wanted to do—he just wanted to “make money,” as if it were that simple.
Knowledge is power but so is misinformation. Small investors need to understand the product and its history. It is important to remember the past, especially if it was revised.
You shouldn’t have to comprehend every minute detail of a scientific process or memorize the molecular chain of the latest product before you invest. You also shouldn’t need a medical dictionary just to read the latest press.
There are many slang words and terms that have crept into the cannabis lexicon over the years. Many are just street terms or colorful jargon, like the many names for the plant. But there is one very ancient word that has been used quite a bit.
Why talk about due diligence? Two words: Bernie Madoff. So what does Bernie Madoff have to do with investing in cannabis? Everything!
If you are trying to create a picture of a cannabis company, you will definitely need perspective. You might consider these art-related metaphors when compiling your files for the companies you research. What you first learn is only a sketch and needs more detail.
The attractiveness of an ETF that could lower the volatility and risk of making an investment into a single cannabis stock is quite evident. But is it feasible?
As cultivation, distribution, medical and personal use become increasingly legal at the state level, entrepreneurs, their friends and family and other early-stage investors are starting to see pathways to harvest.
Oxis Biotech, a subsidiary of Oxis International (OTCQB: OXIS), recently filed a notification to shareholders and the SEC that the company would be entering into a reverse split of not less than 1-50 shares and not more than 1-250 shares.
“Revolutionary,” “history-making” and a “unique opportunity” were among the many catchphrases and adjectives repeated by the attendees of the Marijuana Investor Summit in Denver, April 20-22, 2015.
Ever since the SEC cracked down on marijuana-related investments in 2014, potential investors have been painfully aware of the need to conduct adequate due diligence on the early-stage companies that come courting.
It has been a noteworthy past few days in the realm of investors’ rights. Two different stories that may seem completely unrelated are sewn with some of the same thread, especially for investors that are actively looking at the cannabis space.
Investors in the broad market were pleased to see a turnaround today. Energy stocks showed a rally, overshadowing the fact that Cyber Monday showed lower returns than 2013.
The S&P 500 was off 0.15% after minor selling pressure earlier in the day. NASDAQ was down a little over 0.5%. There is a lot of buzz around the bad behavior of Uber executives … .
It is hard to say that the market was actually manic today, but we had a nice follow on from Friday’s bounce. Market breadth was quite strong, especially given weakness in bellwether blue chip, IBM.
On Saturday, June 7, 2014, The ArcView Group gave a two-hour presentation on cannabis business at the Chicago Cannabis Conference. It was an opportunity for attendees to get a medical marijuana education in law, investment and startups. In the first hour, Troy Dayton, CEO of The ArcView Group, gave a detailed presentation on the cannabis industry.